SUJATHA GERINENI

Allopathic & Osteopathic Physicians|Internal Medicine SAN ANTONIO, TX NPI 1396973640

General Payments — all program years on this page

$3,553.13

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 130
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $334.85 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $334.8517

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $385.9517
2019 $313.8124
2020 $221.898
2021 $1,025.0622
2022 $929.7629
2023 $341.8113
2024 $334.8517

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092635363 Boston Scientific Corporation $23.77 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097410469 Novo Nordisk Inc $13.66 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097501926 Novo Nordisk Inc $16.40 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097579707 Novo Nordisk Inc $23.67 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1099890959 ALK-Abello, Inc $17.56 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104393561 AstraZeneca Pharmaceuticals LP $18.42 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104747071 AstraZeneca Pharmaceuticals LP $21.35 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105466659 AstraZeneca Pharmaceuticals LP $14.85 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114672257 Exact Sciences Corporation $15.43 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116222567 GlaxoSmithKline, LLC. $15.91 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116350492 GlaxoSmithKline, LLC. $30.61 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120060683 SI-BONE, INC. $24.91 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120075680 SI-BONE, INC. $20.99 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130976390 PFIZER INC. $13.63 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135351299 Lilly USA, LLC $20.88 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135408951 Lilly USA, LLC $28.24 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153561659 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.57 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.